FSOSX
Price
$16.01
Change
+$0.17 (+1.07%)
Updated
Sep 26 closing price
Net Assets
15.56B
RERCX
Price
$61.84
Change
+$0.19 (+0.31%)
Updated
Sep 26 closing price
Net Assets
135.04B
Interact to see
Advertisement

FSOSX vs RERCX

Header iconFSOSX vs RERCX Comparison
Open Charts FSOSX vs RERCXBanner chart's image
Fidelity Series Overseas
Price$16.01
Change+$0.17 (+1.07%)
VolumeN/A
Net Assets15.56B
American Funds EUPAC R3
Price$61.84
Change+$0.19 (+0.31%)
VolumeN/A
Net Assets135.04B
FSOSX vs RERCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSOSX vs. RERCX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSOSX is a Buy and RERCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERCX has more cash in the bank: 135B vs. FSOSX (15.6B). FSOSX pays higher dividends than RERCX: FSOSX (1.90) vs RERCX (0.49). FSOSX was incepted earlier than RERCX: FSOSX (6 years) vs RERCX (23 years). RERCX (1.12) is less costly to investors than FSOSX (0.01). FSOSX (36.00) and RERCX (35.00) have comparable annual turnover. FSOSX has a lower initial minimum investment than RERCX: FSOSX (0) vs RERCX (250). FSOSX annual gain was more profitable for investors over the last year : 6.54 vs. RERCX (5.19). FSOSX return over 5 years is better than : 55.48 vs. RERCX (14.81).
FSOSXRERCXFSOSX / RERCX
Total Expense Ratio0.011.121%
Annual Report Gross Expense Ratio0.011.121%
Fund Existence6 years23 years-
Gain YTD17.85718.55896%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets15.6B135B12%
Annual Yield % from dividends1.900.49388%
Returns for 1 year6.545.19126%
Returns for 3 years77.8449.58157%
Returns for 5 years55.4814.81375%
Returns for 10 yearsN/A47.52-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMRN53.851.23
+2.34%
BioMarin Pharmaceutical
CTKB3.400.01
+0.29%
Cytek Biosciences
SDRL31.400.01
+0.03%
Seadrill Limited
VRAX0.61-0.01
-2.26%
Virax Biolabs Group Limited
TDTH0.92-0.04
-4.17%
Trident Digital Tech Holdings Ltd